Clinical Development, Alba Therapeutics, 800 W. Baltimore St, Suite 400, Baltimore, MD 21201, USA.
J Immunol Methods. 2011 Jan 5;363(2):177-86. doi: 10.1016/j.jim.2010.09.002. Epub 2010 Sep 15.
This article reviews the multiple uses of flow cytometry in the diagnosis, monitoring and research of celiac disease, the most prevalent chronic autoimmune gastrointestinal disease. The phenotyping of intraepithelial lymphocytes (IELs) is of clinical relevance in the diagnosis of the disease given the characteristic features of elevated CD3+ IELs (αβ and γδ TcR) and the decrease in CD3- IELs. IEL biomarkers are also useful in the assessment of the response to the gluten-free diet and, importantly, in the diagnosis of the severe complications of celiac disease: refractory celiac disease and enteropathy-associated T-cell lymphoma. Novel applications of flow cytometry for the detection of anti-transglutaminase antibodies (a validated biomarker of celiac disease) and of gluten (the triggering antigen of the autoimmune process) are also discussed. The assessment of diagnostic and prognostic biomarkers by flow cytometry in celiac disease is performed routinely in a growing number of centers and it is an example of the versatility of this technique and its applicability to the research and clinical study of solid tissues.
本文综述了流式细胞术在乳糜泻(最常见的慢性自身免疫性胃肠道疾病)的诊断、监测和研究中的多种用途。鉴于上皮内淋巴细胞(IELs)中 CD3+ IELs(αβ 和 γδ TCR)升高和 CD3- IELs 减少的特征,对 IELs 的表型分析对疾病的诊断具有临床意义。IEL 生物标志物在评估无麸质饮食的反应以及重要的是评估乳糜泻的严重并发症(难治性乳糜泻和肠病相关 T 细胞淋巴瘤)方面也很有用。本文还讨论了流式细胞术用于检测抗转谷氨酰胺酶抗体(乳糜泻的一种验证性生物标志物)和 gluten(自身免疫过程的触发抗原)的新应用。在越来越多的中心,通过流式细胞术评估乳糜泻的诊断和预后生物标志物已成为常规操作,这是该技术多功能性及其在实体组织的研究和临床研究中的适用性的一个例子。